Lobby organisation
Miltenyi Biomedicine GmbH
Company · Health & pharma · HQ: Germany · Transparency Register entry
As of 8 October 2026, Miltenyi Biomedicine GmbH appears in 4 declared MEP meetings (4 different MEPs), most often with European People's Party.
In their own words
“Miltenyi Biomedicine is a clinical-stage biopharmaceutical company focused on developing effective cell therapies. Our clinical programs are built on decades of expertise in cell processing, automation, and GMP manufacturing. Our mission is to expand access to cell therapies for patients with difficult-to-treat indications. Our current focus is on hematological cancers, with investigational CAR-T programs in development.”
Read the rest of the statementShow less of the statement
“Our goal is to increase the number of patients who can benefit from next-generation cell and gene therapies by offering more effective treatment options and reducing time to treatment (for more information explore our pipeline).”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 4 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2025–2025. Bar length is relative to its busiest year (4 in 2025). All meetings were in one calendar year.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 4 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 30 Sep 2025 | Nicolás González Casares | Pharmaceutical legislation |
| 11 Sep 2025 | Aurelijus Veryga | Improving Patient Access through Decentralized Manufacturing |
| 28 Jul 2025 | Oliver Schenk | EU Pharmaceutical Legislation |
| 2 Jul 2025 | Tomislav Sokol | Health policy |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.